Novo Nordisk Shares Tumble as Wegovy Sales Growth Fails to Meet High Investor Expectations
The pharmaceutical landscape experienced a significant jolt this week as Novo Nordisk reported financial results that left many investors questioning the long
by 
Josh Weiner
Josh Weiner